OneAscent Financial Services’s GSK GSK Stock Holding History

OneAscent Financial Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Sell	6,814 -62	-0.9%	-$3.28K	0.02%	453
2026 Q1	$379K	Buy	6,876 +2,207	+47%	+$120K	0.02%	400
2025 Q4	$229K	Buy	+4,669	New	+$218K	0.02%	415
2025 Q3	–	Sell	-6,423	Closed	-$249K	–	516
2025 Q2	$249K	Sell	6,423 -1,277	-17%	-$48.8K	0.02%	459
2025 Q1	$297K	Buy	7,700 +292	+4%	+$10.7K	0.02%	402
2024 Q4	$251K	Buy	7,408 +1,495	+25%	+$53.8K	0.02%	395
2024 Q3	$244K	Sell	5,913 -243	-4%	-$9.94K	0.18%	155
2024 Q2	$239K	Sell	6,156 -1,097	-15%	-$46.1K	0.03%	214
2024 Q1	$313K	Sell	7,253 -158	-2%	-$6.52K	0.03%	280
2023 Q4	$275K	Buy	7,411 +17	+0.2%	+$610	0.03%	285
2023 Q3	$268K	Buy	+7,394	New	+$262K	0.07%	196
2022 Q1	–	Sell	-4,448	Closed	-$245K	–	168
2021 Q4	$245K	Buy	+4,448	New	+$231K	0.47%	97

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

OneAscent Financial Services's GSK Position: Q2 2026 in Review

OneAscent Financial Services reduced its GSK (GSK) stake by 0.9% in Q2 2026, selling an estimated $3.28K and leaving 6,814 shares worth $357K. The position accounts for 0.02% of the portfolio, ranked #453.

OneAscent Financial Services first reported a position in GSK in Q4 2021 and has held it in 12 quarters since. The position peaked at $379K in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

OneAscent Financial Services held 6,814 shares of GSK worth $357K as of Q2 2026.
OneAscent Financial Services sold 62 GSK shares in Q2 2026, an estimated $3.28K.
GSK made up 0.02% of OneAscent Financial Services's portfolio in Q2 2026, its #453 holding.
OneAscent Financial Services first reported a position in GSK in Q4 2021 and has held it in 12 quarters since.
OneAscent Financial Services's GSK position peaked at $379K in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.